Cargando…
Tumour ablation: technical aspects
Image-guided percutaneous radiofrequency ablation (RFA) is a minimally invasive, relatively low-risk procedure for tumour treatment. Local recurrence and survival rates depend on the rate of complete ablation of the entire tumour including a sufficient margin of surrounding healthy tissue. Currently...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
e-Med
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797459/ https://www.ncbi.nlm.nih.gov/pubmed/19965296 http://dx.doi.org/10.1102/1470-7330.2009.9026 |
_version_ | 1782175621804195840 |
---|---|
author | Widmann, Gerlig Bodner, Gerd Bale, Reto |
author_facet | Widmann, Gerlig Bodner, Gerd Bale, Reto |
author_sort | Widmann, Gerlig |
collection | PubMed |
description | Image-guided percutaneous radiofrequency ablation (RFA) is a minimally invasive, relatively low-risk procedure for tumour treatment. Local recurrence and survival rates depend on the rate of complete ablation of the entire tumour including a sufficient margin of surrounding healthy tissue. Currently a variety of different RFA devices are available. The interventionalist must be able to predict the configuration and extent of the resulting ablation necrosis. Accurate planning and execution of RFA according to the size and geometry of the tumour is essential. In order to minimize complications, individualized treatment strategies may be necessary for tumours close to vital structures. This review examines the state-of-the art of different device technologies, approaches, and treatment strategies for percutaneous RFA of liver tumours. |
format | Text |
id | pubmed-2797459 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | e-Med |
record_format | MEDLINE/PubMed |
spelling | pubmed-27974592011-10-02 Tumour ablation: technical aspects Widmann, Gerlig Bodner, Gerd Bale, Reto Cancer Imaging Tumour Ablation Image-guided percutaneous radiofrequency ablation (RFA) is a minimally invasive, relatively low-risk procedure for tumour treatment. Local recurrence and survival rates depend on the rate of complete ablation of the entire tumour including a sufficient margin of surrounding healthy tissue. Currently a variety of different RFA devices are available. The interventionalist must be able to predict the configuration and extent of the resulting ablation necrosis. Accurate planning and execution of RFA according to the size and geometry of the tumour is essential. In order to minimize complications, individualized treatment strategies may be necessary for tumours close to vital structures. This review examines the state-of-the art of different device technologies, approaches, and treatment strategies for percutaneous RFA of liver tumours. e-Med 2009-10-02 /pmc/articles/PMC2797459/ /pubmed/19965296 http://dx.doi.org/10.1102/1470-7330.2009.9026 Text en © 2009 International Cancer Imaging Society |
spellingShingle | Tumour Ablation Widmann, Gerlig Bodner, Gerd Bale, Reto Tumour ablation: technical aspects |
title | Tumour ablation: technical aspects |
title_full | Tumour ablation: technical aspects |
title_fullStr | Tumour ablation: technical aspects |
title_full_unstemmed | Tumour ablation: technical aspects |
title_short | Tumour ablation: technical aspects |
title_sort | tumour ablation: technical aspects |
topic | Tumour Ablation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797459/ https://www.ncbi.nlm.nih.gov/pubmed/19965296 http://dx.doi.org/10.1102/1470-7330.2009.9026 |
work_keys_str_mv | AT widmanngerlig tumourablationtechnicalaspects AT bodnergerd tumourablationtechnicalaspects AT balereto tumourablationtechnicalaspects |